PSMA-PET Imaging in Patients With Metastatic Prostate Cancer: Institutional Evaluation of Detection Yield Performance and Reproducibility
Condition(s):Prostate CancerLast Updated:July 17, 2020Completed
Hide Studies Not Open or Pending
Condition(s):Prostate CancerLast Updated:July 17, 2020Completed
Condition(s):High-grade Glioma; Brain Metastases; Brain Metastases, AdultLast Updated:February 22, 2024Recruiting
Condition(s):Prostate CancerLast Updated:February 21, 2024Recruiting
Condition(s):Stage II Prostate Adenocarcinoma; Stage III Prostate AdenocarcinomaLast Updated:March 4, 2022Completed
Condition(s):Prostate Cancer; Prostatic Hyperplasia; Prostatic Neoplasms; Prostate Cancer Metastatic; Neuroendocrine Tumors; Neuroendocrine CarcinomaLast Updated:February 6, 2024Not yet recruiting
Condition(s):Salivary Gland Cancer; Salivary Duct CarcinomaLast Updated:August 16, 2022Recruiting
Condition(s):Thyroid Gland CarcinomaLast Updated:June 29, 2021Terminated
Condition(s):Prostate Cancer DiagnosisLast Updated:April 24, 2023Not yet recruiting
Condition(s):Neurodegenerative Diseases; Brain Neoplasms; Neuroendocrine TumorsLast Updated:January 18, 2024Completed
Condition(s):Prostate Cancer; Lymph Node MetastasesLast Updated:July 21, 2017Unknown status
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.